UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

A proposed pathway from D-glucose to D-arabinose in eukaryotes

The Journal of biological chemistry, 2024-08, Vol.300 (8), p.107500, Article 107500

2024

Volltextzugriff (PDF)

Streptococcal dTDP‐L‐rhamnose biosynthesis enzymes: functional characterization and lead compound identification

Molecular microbiology, 2019-04, Vol.111 (4), p.951-964

2019

Volltextzugriff (PDF)

DFT in a nutshell

International journal of quantum chemistry, 2013-01, Vol.113 (2), p.96-101

2013

Volltextzugriff (PDF)

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

Cancer cell, 2017-06, Vol.31 (6), p.833-843.e5

2017

Volltextzugriff (PDF)

One-dimensional continuum electronic structure with the density-matrix renormalization group and its implications for density-functional theory

Physical review letters, 2012-08, Vol.109 (5), p.056402-056402, Article 056402

2012

Volltextzugriff (PDF)

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

Journal of clinical oncology, 2020-08, Vol.38 (22), p.2519-2529

2020

Volltextzugriff (PDF)

Guaranteed convergence of the Kohn-Sham equations

Physical review letters, 2013-08, Vol.111 (9), p.093003-093003, Article 093003

2013

Volltextzugriff (PDF)

One-dimensional mimicking of electronic structure: The case for exponentials

Physical review. B, Condensed matter and materials physics, 2015-06, Vol.91 (23), Article 235141

2015

Volltextzugriff (PDF)

Kohn-Sham calculations with the exact functional

Physical review. B, Condensed matter and materials physics, 2014-07, Vol.90 (4), Article 045109

2014

Volltextzugriff (PDF)

Reference electronic structure calculations in one dimension

Physical chemistry chemical physics : PCCP, 2012-06, Vol.14 (24), p.8581-8590

2012

Volltextzugriff (PDF)

Response-Adapted Therapy in HIV-Associated Diffuse Large B-Cell Lymphoma: Updated Results of a Prospective Phase II Study of Short-Course-EPOCH-RR

Blood, 2019-11, Vol.134 (Supplement_1), p.4080-4080

2019

Volltextzugriff (PDF)

Phase 2 Study of Alemtuzumab Added to Dose-Adjusted EPOCH-R in Relapsed and Refractory Aggressive B-Cell Lymphomas

Blood, 2019-11, Vol.134 (Supplement_1), p.4102-4102

2019

Volltextzugriff (PDF)

Prognostic Factors Other Than Age Drive the Risk of Disease Progression in Adults with Burkitt Lymphoma Treated with DA-EPOCH-R

Blood, 2021-11, Vol.138 (Supplement 1), p.453-453

2021

Volltextzugriff (PDF)

Circulating Tumor DNA Dynamics during Therapy Predict Outcomes in Mantle Cell Lymphoma

Blood, 2018-11, Vol.132 (Supplement 1), p.147-147

2018

Volltextzugriff (PDF)

Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial

The Lancet. Haematology, 2023-05, Vol.10 (5), p.e346-e358

2023

Volltextzugriff (PDF)

Erratum: DFT in a nutshell

International journal of quantum chemistry, 2013-05, Vol.113 (10), p.1601-1601

2013

Volltextzugriff (PDF)

Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma

Blood advances, 2022-04, Vol.6 (8), p.2667-2680

2022

Volltextzugriff (PDF)

Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R

Blood advances, 2023-09, Vol.7 (18), p.5320-5324

2023

Volltextzugriff (PDF)

Erratum: Guaranteed Convergence of the Kohn-Sham Equations [Phys. Rev. Lett. 111, 093003 (2013)]

Physical review letters, 2014-01, Vol.112 (1), Article 019901

2014

Volltextzugriff (PDF)

Pharmacokinetics and Tolerability of Etoposide in Newly Diagnosed Lymphoma Patients with Hepatic Impairment

Blood, 2014-12, Vol.124 (21), p.4445-4445

2014

Volltextzugriff (PDF)

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary Central Nervous System Lymphoma

Cancer cell, 2017-05, Vol.31 (6), p.833-843.e5

2017

Volltextzugriff (PDF)

Reference electronic structure calculations in one dimensionThis article was submitted as part of a Themed Issue on fragment and localized orbital methods in electronic structure theory. Other papers on this topic can be found in issue 21 of vol. 14 (2012). This issue can be found from the PCCP homepage [http://www.rsc.org/pccp]

2012-05

Volltextzugriff (PDF)

Phase I Study of Dose-Adjusted-Teddi-R with Ibrutinib in Untreated and Relapsed/Refractory Primary CNS Lymphoma

Blood, 2015-12, Vol.126 (23), p.472-472

2015

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(31)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(7)
Humans
(6)
Physical Sciences
(6)
Physics
(6)
Adult
(4)
Female
(4)
Hematology
(4)
Male
(4)
Aged
(3)
Aged, 80 And Over
(3)
Chemistry
(3)
Density
(3)
Middle Aged
(3)
Technology
(3)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(2)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)
Approximation
(2)
Burkitt Lymphoma - Drug Therapy
(2)
Chemistry, Physical
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A proposed pathway from D-glucose to D-arabinose in eukaryotes

Streptococcal dTDP‐L‐rhamnose biosynthesis enzymes: functional characterization and lead compound identification

DFT in a nutshell

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

One-dimensional continuum electronic structure with the density-matrix renormalization group and its implications for density-functional theory

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

Guaranteed convergence of the Kohn-Sham equations

One-dimensional mimicking of electronic structure: The case for exponentials

Kohn-Sham calculations with the exact functional

Reference electronic structure calculations in one dimension

Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study

Response-Adapted Therapy in HIV-Associated Diffuse Large B-Cell Lymphoma: Updated Results of a Prospective Phase II Study of Short-Course-EPOCH-RR

Phase 2 Study of Alemtuzumab Added to Dose-Adjusted EPOCH-R in Relapsed and Refractory Aggressive B-Cell Lymphomas

Prognostic Factors Other Than Age Drive the Risk of Disease Progression in Adults with Burkitt Lymphoma Treated with DA-EPOCH-R

Circulating Tumor DNA Dynamics during Therapy Predict Outcomes in Mantle Cell Lymphoma

Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial

Erratum: DFT in a nutshell

Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma

Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R

Erratum: Guaranteed Convergence of the Kohn-Sham Equations [Phys. Rev. Lett. 111, 093003 (2013)]

Pharmacokinetics and Tolerability of Etoposide in Newly Diagnosed Lymphoma Patients with Hepatic Impairment

Risk-Adapted Therapy in Adults with Burkitt Lymphoma: Results of NCI 9177, a Multicenter Prospective Phase II Study of DA-EPOCH-R

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary Central Nervous System Lymphoma

Phase I Study of Dose-Adjusted-Teddi-R with Ibrutinib in Untreated and Relapsed/Refractory Primary CNS Lymphoma

Suchergebnisse filtern